Search research articles
Contact Us
Filters
Showing results (61-70 of 162) with videos related to
Page
of 17
Sort By:
Journal of Neuroscience Research
|
June 16, 2004
Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis
Agata Matejuk, Antony C Bakke, Corwyn Hopke, et al.
Metabolic Brain Disease
|
July 10, 2017
Estrogen protects both sexes against EAE by promoting common regulatory cell subtypes independent of endogenous estrogen
Hilary A Seifert, Gil Benedek, Ha Nguyen, et al.
Translational Stroke Research
|
November 5, 2013
Phenotypic changes in immune cell subsets reflect increased infarct volume in male vs. female mice
Anirban Banerjee, Jianming Wang, Sheetal Bodhankar, et al.
Journal of Neuroinflammation
|
June 25, 2015
HLA-DRα1-mMOG-35-55 treatment of experimental autoimmune encephalomyelitis reduces CNS inflammation, enhances M2 macrophage frequency, and promotes neuroprotection
Gil Benedek, Roberto Meza-Romero, Kelley Jordan, et al.
Translational Stroke Research
|
December 3, 2015
Partial MHC Constructs Treat Thromboembolic Ischemic Stroke Characterized by Early Immune Expansion
Abby L Dotson, Yingxin Chen, Wenbin Zhu, et al.
Metabolic Brain Disease
|
August 7, 2015
Role for microglia in sex differences after ischemic stroke: importance of M2
Sheetal Bodhankar, Andrew Lapato, Yingxin Chen, et al.
Translational Stroke Research
|
June 24, 2014
Recombinant T cell receptor ligand treatment improves neurological outcome in the presence of tissue plasminogen activator in experimental ischemic stroke
Wenbin Zhu, Nicole L Libal, Amanda Casper, et al.
Immunology
|
March 24, 2009
Oestrogen modulates experimental autoimmune encephalomyelitis and interleukin-17 production via programmed death 1
Chunhe Wang, Babak Dehghani, Yuexin Li, et al.
Frontiers in Cellular Neuroscience
|
August 27, 2014
Targeting immune co-stimulatory effects of PD-L1 and PD-L2 might represent an effective therapeutic strategy in stroke
Sheetal Bodhankar, Yingxin Chen, Andrew Lapato, et al.
Plos One
|
July 14, 2011
RTL551 treatment of EAE reduces CD226 and T-bet+ CD4 T cells in periphery and prevents infiltration of T-bet+ IL-17, IFN-γ producing T cells into CNS
Sushmita Sinha, Lisa M Miller, Sandhya Subramanian, et al.
Page
of 17
Search research articles
Search
Showing results (61-70 of 162) with videos related to
Sort By:
Page
of 17
Journal of Neuroscience Research
|
June 16, 2004
Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis
Agata Matejuk, Antony C Bakke, Corwyn Hopke, et al.
Metabolic Brain Disease
|
July 10, 2017
Estrogen protects both sexes against EAE by promoting common regulatory cell subtypes independent of endogenous estrogen
Hilary A Seifert, Gil Benedek, Ha Nguyen, et al.
Translational Stroke Research
|
November 5, 2013
Phenotypic changes in immune cell subsets reflect increased infarct volume in male vs. female mice
Anirban Banerjee, Jianming Wang, Sheetal Bodhankar, et al.
Journal of Neuroinflammation
|
June 25, 2015
HLA-DRα1-mMOG-35-55 treatment of experimental autoimmune encephalomyelitis reduces CNS inflammation, enhances M2 macrophage frequency, and promotes neuroprotection
Gil Benedek, Roberto Meza-Romero, Kelley Jordan, et al.
Translational Stroke Research
|
December 3, 2015
Partial MHC Constructs Treat Thromboembolic Ischemic Stroke Characterized by Early Immune Expansion
Abby L Dotson, Yingxin Chen, Wenbin Zhu, et al.
Metabolic Brain Disease
|
August 7, 2015
Role for microglia in sex differences after ischemic stroke: importance of M2
Sheetal Bodhankar, Andrew Lapato, Yingxin Chen, et al.
Translational Stroke Research
|
June 24, 2014
Recombinant T cell receptor ligand treatment improves neurological outcome in the presence of tissue plasminogen activator in experimental ischemic stroke
Wenbin Zhu, Nicole L Libal, Amanda Casper, et al.
Immunology
|
March 24, 2009
Oestrogen modulates experimental autoimmune encephalomyelitis and interleukin-17 production via programmed death 1
Chunhe Wang, Babak Dehghani, Yuexin Li, et al.
Frontiers in Cellular Neuroscience
|
August 27, 2014
Targeting immune co-stimulatory effects of PD-L1 and PD-L2 might represent an effective therapeutic strategy in stroke
Sheetal Bodhankar, Yingxin Chen, Andrew Lapato, et al.
Plos One
|
July 14, 2011
RTL551 treatment of EAE reduces CD226 and T-bet+ CD4 T cells in periphery and prevents infiltration of T-bet+ IL-17, IFN-γ producing T cells into CNS
Sushmita Sinha, Lisa M Miller, Sandhya Subramanian, et al.
Page
of 17